Presentations are available now (OMF meeting Nov 9,2016)
(click the presenter name to view or download the presentation)
- 0-Atul Butte(Moderator); Introducing the R01 Teams
- 1-Emily Poulin/Kevin Haigis; Modeling K-Ras genetic heterogeneity in mouse models
- 2-Michael Shen; Analysis of drug response in organoids and mouse models
- 3-Monte Winslow; A quantitative multiplexed platform for the pharmacogenomic analysis of lung cancer
- 4-Eric Holland; Using genetically engineered models of brain tumors to develop therapeutic nanoparticles and biomaterials
- 5-Marcus Bosenberg; Congenic mouse models of melanoma for the characterization of tumor immune response
- 6-Kathleen Cho;Credentialing ovarian cancer models in the context of the dualistic pathway paradigm
- 7-Edgar Engleman; Applicability of mouse breast cancer models to tumor-immune network investigation
- 8-Sara Meyer/Lee Grimes; A rapid spontaneous murine model of cytogenetically normal acute myeloid leukemia
- 9-Constantine Mitsiades; Humanized bone marrow-like model to study patient-derived myeloma xenografts
- 10-David Gutmann; Leveraging genetically-engineered mice to optimize pediatric glioma management
- 11-Charles Perou; Credentialing mouse models for immune system therapy research
- 12-Luke Dow/Scott Lowe; A scalable platform for target validation in GEMM models of gastrointestinal malignancies
- 13-Charles Perou; Mouse models of metastatic triple-negative breast cancer for therapeutic testing
- 14-Raghu Kalluri; Employing mouse models to translate early detection of pancreas cancer
- 15-Katarina Politi; Targeting the immune system in mouse models of lung adenocarcinoma
- 16-William Murphy; Enhancing translational therapeutics utilizing biologically, immunologically, and metabolically relevant models of breast cancer
- 17-Jennifer Barton; Validating a mouse model of ovarian cancer for early detection through imaging
- 18-Karolina Palucka; Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
- 19-Jeff Wiser; How to enter data sets into the Immunology Portal (ImmPort) database
- 20-Dvir Aran; Studying the Tumor Microenvironment with Big Data
- 21-Bin Chen; Relating tumor samples and cell lines to make more precise therapeutic prediction
- 22-Ted Goldstein #(Moderator); Open Discussion on Topics from Forum PI
- Note
- If your presentation slide is not in the hub-OMF yet, you can upload the file from your local to this linked directory:
* click Here to upload
Click the green “Upload” in that page.
Created on , Last modified on